JP2009523028A5 - - Google Patents

Download PDF

Info

Publication number
JP2009523028A5
JP2009523028A5 JP2008550454A JP2008550454A JP2009523028A5 JP 2009523028 A5 JP2009523028 A5 JP 2009523028A5 JP 2008550454 A JP2008550454 A JP 2008550454A JP 2008550454 A JP2008550454 A JP 2008550454A JP 2009523028 A5 JP2009523028 A5 JP 2009523028A5
Authority
JP
Japan
Prior art keywords
expression level
normalized
normalized expression
colorectal cancer
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008550454A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009523028A (ja
JP5297202B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/000995 external-priority patent/WO2007082099A2/en
Publication of JP2009523028A publication Critical patent/JP2009523028A/ja
Publication of JP2009523028A5 publication Critical patent/JP2009523028A5/ja
Application granted granted Critical
Publication of JP5297202B2 publication Critical patent/JP5297202B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008550454A 2006-01-11 2007-01-11 結腸直腸癌の予後のための遺伝子発現マーカー Active JP5297202B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US75839206P 2006-01-11 2006-01-11
US60/758,392 2006-01-11
US80027706P 2006-05-12 2006-05-12
US60/800,277 2006-05-12
US81007706P 2006-05-31 2006-05-31
US60/810,077 2006-05-31
PCT/US2007/000995 WO2007082099A2 (en) 2006-01-11 2007-01-11 Gene expression markers for colorectal cancer prognosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012272400A Division JP5486664B2 (ja) 2006-01-11 2012-12-13 結腸直腸癌の予後のための遺伝子発現マーカー

Publications (3)

Publication Number Publication Date
JP2009523028A JP2009523028A (ja) 2009-06-18
JP2009523028A5 true JP2009523028A5 (enExample) 2010-03-18
JP5297202B2 JP5297202B2 (ja) 2013-09-25

Family

ID=38257063

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2008550454A Active JP5297202B2 (ja) 2006-01-11 2007-01-11 結腸直腸癌の予後のための遺伝子発現マーカー
JP2012272400A Active JP5486664B2 (ja) 2006-01-11 2012-12-13 結腸直腸癌の予後のための遺伝子発現マーカー
JP2013124949A Active JP5486718B2 (ja) 2006-01-11 2013-06-13 結腸直腸癌の予後のための遺伝子発現マーカー
JP2013124950A Active JP5486719B2 (ja) 2006-01-11 2013-06-13 結腸直腸癌の予後のための遺伝子発現マーカー
JP2013124952A Pending JP2013215201A (ja) 2006-01-11 2013-06-13 結腸直腸癌の予後のための遺伝子発現マーカー
JP2013124948A Active JP5486717B2 (ja) 2006-01-11 2013-06-13 結腸直腸癌の予後のための遺伝子発現マーカー
JP2013124951A Active JP5486720B2 (ja) 2006-01-11 2013-06-13 結腸直腸癌の予後のための遺伝子発現マーカー

Family Applications After (6)

Application Number Title Priority Date Filing Date
JP2012272400A Active JP5486664B2 (ja) 2006-01-11 2012-12-13 結腸直腸癌の予後のための遺伝子発現マーカー
JP2013124949A Active JP5486718B2 (ja) 2006-01-11 2013-06-13 結腸直腸癌の予後のための遺伝子発現マーカー
JP2013124950A Active JP5486719B2 (ja) 2006-01-11 2013-06-13 結腸直腸癌の予後のための遺伝子発現マーカー
JP2013124952A Pending JP2013215201A (ja) 2006-01-11 2013-06-13 結腸直腸癌の予後のための遺伝子発現マーカー
JP2013124948A Active JP5486717B2 (ja) 2006-01-11 2013-06-13 結腸直腸癌の予後のための遺伝子発現マーカー
JP2013124951A Active JP5486720B2 (ja) 2006-01-11 2013-06-13 結腸直腸癌の予後のための遺伝子発現マーカー

Country Status (14)

Country Link
US (10) US7695913B2 (enExample)
EP (9) EP2412822A1 (enExample)
JP (7) JP5297202B2 (enExample)
KR (1) KR20090003178A (enExample)
AU (1) AU2007204826B2 (enExample)
BR (1) BRPI0706511A2 (enExample)
CA (1) CA2636984A1 (enExample)
DK (1) DK1974058T3 (enExample)
ES (1) ES2491222T3 (enExample)
IL (1) IL192794A (enExample)
MX (1) MX2008008973A (enExample)
NO (1) NO20083461L (enExample)
NZ (7) NZ593224A (enExample)
WO (1) WO2007082099A2 (enExample)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004046386A1 (en) 2002-11-15 2004-06-03 Genomic Health, Inc. Gene expression profiling of egfr positive cancer
EP1737980A2 (en) 2004-04-09 2007-01-03 Fondazione IRCCS Istituto Nazionale dei Tumori Gene expression markers for predicting response to chemotherapy
NZ593224A (en) * 2006-01-11 2012-10-26 Genomic Health Inc Gene expression markers (fap) for colorectal cancer prognosis
CN103424541B (zh) 2006-05-18 2018-01-30 分子压型学会股份有限公司 确定针对病状的个性化医疗介入的系统和方法
US8768629B2 (en) 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
US20080234946A1 (en) * 2007-03-22 2008-09-25 University Of South Florida Predictive radiosensitivity network model
US20090076734A1 (en) 2007-03-22 2009-03-19 Torres-Roca Javier F Gene Signature for the Prediction of Radiation Therapy Response
ES2442919T3 (es) 2007-03-27 2014-02-14 Immunovia Ab Firma/marcadores de proteínas para la detección de adenocarcinoma
US20090123920A1 (en) * 2007-11-08 2009-05-14 Maher Albitar Jak2 mutations
ES2332167B1 (es) * 2007-12-04 2010-10-25 Universidad Autonoma De Madrid Empleo de trefoil factor-family 3 (tff3) en el pronostico de sujetos diagnosticados con cancer colorectal.
WO2009123634A1 (en) * 2008-04-02 2009-10-08 Regents Of The University Of California Systems and methods for predicting response of biological samples
US8067178B2 (en) 2008-03-14 2011-11-29 Genomic Health, Inc. Gene expression markers for prediction of patient response to chemotherapy
EP2288727B1 (en) 2008-05-14 2013-07-10 Genomic Health, Inc. Predictors of patient response to treatment with egf receptor inhibitors
US20100029748A1 (en) * 2008-08-04 2010-02-04 Sloan-Kettering Institute For Cancer Research Metastasis Promoting Genes and Proteins
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
US20100221752A2 (en) * 2008-10-06 2010-09-02 Somalogic, Inc. Ovarian Cancer Biomarkers and Uses Thereof
WO2010042228A2 (en) * 2008-10-10 2010-04-15 Cornell University Methods for predicting disease outcome in patients with colon cancer
US20120041274A1 (en) 2010-01-07 2012-02-16 Myriad Genetics, Incorporated Cancer biomarkers
US8765383B2 (en) 2009-04-07 2014-07-01 Genomic Health, Inc. Methods of predicting cancer risk using gene expression in premalignant tissue
SG10201401722XA (en) * 2009-05-01 2014-08-28 Genomic Health Inc Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer andresponse to chemotherapy
TWI513465B (zh) * 2009-06-25 2015-12-21 Regeneron Pharma 以ｄｌｌ４拮抗劑與化學治療劑治療癌症之方法
US20120053253A1 (en) 2010-07-07 2012-03-01 Myriad Genetics, Incorporated Gene signatures for cancer prognosis
CA2801110C (en) 2010-07-09 2021-10-05 Somalogic, Inc. Lung cancer biomarkers and uses thereof
EP2913405B1 (en) 2010-07-27 2016-11-09 Genomic Health, Inc. Method for using gene expression to determine prognosis of prostate cancer
CN106198980B (zh) 2010-08-13 2018-09-07 私募蛋白质体公司 胰腺癌生物标记及其用途
EP2611941A4 (en) 2010-08-30 2014-01-22 Myriad Genetics Inc GENESIS OF CANCER DIAGNOSIS AND PROGNOSIS
MY166040A (en) 2010-09-15 2018-05-21 Almac Diagnostics Ltd Molecular diagnostic test for cancer
BR112013018924A2 (en) 2011-01-25 2018-05-08 Almac Diagnostics Limited Colon cancer gene expression signatures and methods of use
EP2773772A1 (en) * 2011-11-04 2014-09-10 Oslo Universitetssykehus HF Methods and biomarkers for analysis of colorectal cancer
CA2857073A1 (en) 2011-11-28 2013-06-06 Institucio Catalana De Recerca I Estudis Avancats Methods and kits for the prognosis of colorectal cancer
US10519506B2 (en) 2011-12-22 2019-12-31 Baylor Research Institute Identification of metastasis-specific miRNA and hypomethylation signatures in human colorectal cancer
WO2013104990A1 (en) * 2012-01-09 2013-07-18 Oslo Universitetssykehus Hf Methods and biomarkers for analysis of colorectal cancer
US8725426B2 (en) 2012-01-31 2014-05-13 Genomic Health, Inc. Gene expression profile algorithm and test for determining prognosis of prostate cancer
WO2013150167A2 (es) 2012-04-03 2013-10-10 Servicio Andaluz De Salud Modelo de expresión de microarn como indicador de supervivencia en pacientes de cancer colorrectal metastásico
US20160222457A1 (en) * 2012-11-14 2016-08-04 Mayo Foundation For Medical Education And Research Methods and materials for identifying malignant skin lesions
ES2938766T3 (es) 2012-11-16 2023-04-14 Myriad Genetics Inc Firmas génicas para el pronóstico de cáncer
ES2475366B1 (es) * 2012-12-10 2015-05-05 Fundación Imdea Alimentación Métodos y kits para el pronóstico del cáncer colorrectal
WO2014159797A1 (en) 2013-03-14 2014-10-02 Abbott Molecular Inc. Cell preparations and cell supports and their use in theranosis
WO2014191559A1 (en) * 2013-05-30 2014-12-04 Institució Catalana De Recerca I Estudis Avançats Methods and kits for the prognosis of colorectal cancer
US10185809B1 (en) * 2013-10-15 2019-01-22 Iqvia Inc. Patient projection methodology
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
CA2943827A1 (en) * 2014-03-28 2015-10-01 Applied Proteomics, Inc. Protein biomarker profiles for detecting colorectal tumors
EP3143160B1 (en) 2014-05-13 2019-11-06 Myriad Genetics, Inc. Gene signatures for cancer prognosis
US20170275700A1 (en) 2014-08-14 2017-09-28 Mayo Foundation For Medical Education And Research Methods and materials for identifying metastatic malignant skin lesions and treating skin cancer
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
EP3210144B1 (en) 2014-10-24 2020-10-21 Koninklijke Philips N.V. Medical prognosis and prediction of treatment response using multiple cellular signaling pathway activities
ES2857953T3 (es) 2014-10-24 2021-09-29 Koninklijke Philips Nv Pronóstico médico y predicción de la respuesta al tratamiento usando las actividades de múltiples rutas de señalización celular
US10016159B2 (en) 2014-10-24 2018-07-10 Koninklijke Philips N.V. Determination of TGF-β pathway activity using unique combination of target genes
WO2016084130A1 (ja) 2014-11-25 2016-06-02 三菱電機株式会社 空圧式アクチュエータ
US20180148789A1 (en) * 2014-12-01 2018-05-31 University Of Southern California Methods for treating and assessing tumor invasion and metastasis
EP3073268A1 (en) * 2015-03-27 2016-09-28 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Biomarker panel for diagnosing cancer
EP3274440B1 (en) 2015-03-27 2026-03-04 Exact Sciences Corporation Detecting esophageal disorders
EP3281016A1 (en) 2015-04-10 2018-02-14 Applied Proteomics Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
EP3316159A4 (en) 2015-06-25 2019-08-14 Advanced Telecommunications Research Institute International PREDICTIVE EQUIPMENT BASED ON A SYSTEM ASSOCIATED WITH SEVERAL INSTITUTIONS AND PREDICTION PROGRAM
DK3334837T3 (da) 2015-08-14 2021-02-15 Koninklijke Philips Nv Vurdering af nfkb-cellulær signaleringsvejaktivitet under anvendelse af matematisk modellering af målgenekspression
EP3466446B1 (en) 2016-03-29 2023-12-27 Karydo Therapeutix, Inc. Pharmaceutical composition or food composition, and method for assessing effect of active ingredient in vivo
CN114594268A (zh) 2016-03-29 2022-06-07 无限生物制药公司 用以预防或治疗肾脏疾病的活性组分的候选物质的筛选装置和筛选方法
AU2017261688B2 (en) 2016-05-10 2022-09-29 Mayo Foundation For Medical Education And Research Methods and materials for staging and treating skin cancer
WO2018165532A1 (en) 2017-03-10 2018-09-13 Baylor Research Institute Methods for diagnosing and treating gastric cancer using mirna expression
WO2018224731A1 (en) * 2017-06-05 2018-12-13 Ls Cancerdiag Oy A method for determining whether a subject is at risk to develop cancer and tools related thereto
EP3461915A1 (en) 2017-10-02 2019-04-03 Koninklijke Philips N.V. Assessment of jak-stat1/2 cellular signaling pathway activity using mathematical modelling of target gene expression
EP3461916A1 (en) 2017-10-02 2019-04-03 Koninklijke Philips N.V. Assessment of jak-stat3 cellular signaling pathway activity using mathematical modelling of target gene expression
EP3502279A1 (en) 2017-12-20 2019-06-26 Koninklijke Philips N.V. Assessment of mapk-ap 1 cellular signaling pathway activity using mathematical modelling of target gene expression
JP7027179B2 (ja) * 2018-01-24 2022-03-01 キヤノン株式会社 給送回転体、シート給送装置及び画像形成装置
US11549152B2 (en) 2018-03-08 2023-01-10 University Of Notre Dame Du Lac Products for assessing colorectal cancer molecular subtype and risk of recurrence and for determining and administering treatment protocols based thereon
KR102007450B1 (ko) * 2018-05-31 2019-08-05 한국과학기술연구원 대장암 치료제 발굴을 위한 신규 표적 치료 작용점의 스크리닝 방법 및 이를 이용하여 선별한 대장암 치료 예후 바이오마커
CN113039289B (zh) 2018-07-25 2025-11-07 斯凯莱恩迪艾克斯有限公司 预测黑色素瘤转移和患者预后的基因特征
EP3886809A4 (en) 2018-11-28 2022-03-30 Genascence Corporation METHODS AND COMPOSITIONS FOR THE TREATMENT OF OSTEOARTHRITIS
WO2020123699A1 (en) * 2018-12-11 2020-06-18 The Trustees Of Columbia University In The City Of New York Compounds and compositions that cause mycn and/or cmyc degradation and methods of use thereof
CN110257518B (zh) * 2019-07-01 2022-08-02 复旦大学附属中山医院 一种用于预测转移性结直肠癌转化治疗疗效的基因集
US12057959B2 (en) * 2019-12-31 2024-08-06 Mcafee, Llc Device identification
KR102263984B1 (ko) * 2020-02-21 2021-06-11 재단법인 아산사회복지재단 직장암 환자에서 수술-전 화학방사선치료의 반응을 예측하기 위한 분석방법
KR102535150B1 (ko) * 2020-04-14 2023-05-23 주식회사 베르티스 암의 예후 예측용 조성물
KR20230017206A (ko) * 2020-04-29 2023-02-03 프리놈 홀딩스, 인크. 결장 세포 증식성 장애를 식별하기 위한 rna 마커 및 방법
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
CN112322730B (zh) * 2020-10-16 2023-04-18 上海市第一人民医院 预测肿瘤耐药、复发的标志物kifc1及其抑制剂和应用
EP4026918A1 (en) * 2021-01-12 2022-07-13 Koninklijke Philips N.V. Prediction of an outcome of a colorectal cancer subject
CN113667673B (zh) * 2021-07-15 2024-02-06 武汉血液中心 一种类孟买血型FUT1 236delG等位基因及其检测方法和应用
KR20230059642A (ko) * 2021-10-26 2023-05-03 사회복지법인 삼성생명공익재단 miRNA를 포함하는 대장암의 치료 및 전이 억제용 조성물 및 이의 용도
CN116735874B (zh) * 2022-03-11 2025-09-23 上海市免疫学研究所 结直肠癌肿瘤边界细胞亚群标志物组合及其应用
US20260043086A1 (en) * 2022-08-06 2026-02-12 H. Lee Moffitt Cancer Center And Research Institute, Inc. Predictive biomarker in avastin in colon cancer

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020172987A1 (en) 1998-02-12 2002-11-21 Terstappen Leon W.M.M. Methods and reagents for the rapid and efficient isolation of circulating cancer cells
GB2339200B (en) 1998-06-06 2001-09-12 Genostic Pharma Ltd Genostics
AU4158799A (en) 1998-06-06 1999-12-30 Genostic Pharma Limited Probes used for genetic filing
EP1131470A4 (en) 1998-10-28 2004-11-10 Vysis Inc CELLULAR NETWORKS AND METHODS FOR DETECTION AND USE OF GENETIC DISORDER MARKERS
EP0999016B1 (en) * 1998-11-06 2001-07-11 Temco S. R. L. Cutter for cross cutting of webs
US6692916B2 (en) 1999-06-28 2004-02-17 Source Precision Medicine, Inc. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
US6960439B2 (en) 1999-06-28 2005-11-01 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
AU7721500A (en) 1999-09-29 2001-04-30 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
EP1274463A2 (en) 1999-12-10 2003-01-15 Whitehead Institute For Biomedical Research Metastasis genes and uses thereof
US7029677B2 (en) * 2000-01-25 2006-04-18 Nuvelo, Inc. Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells
US20040076956A1 (en) 2000-04-06 2004-04-22 Alexander Olek Diagnosis of diseases associated with dna repair
WO2005000087A2 (en) 2003-06-03 2005-01-06 Chiron Corporation Gene products differentially expressed in cancerous colon cells and their methods of use ii
US20020110832A1 (en) 2000-08-03 2002-08-15 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20030166064A1 (en) 2000-08-03 2003-09-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
AU2001280982A1 (en) 2000-08-03 2002-02-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20030077568A1 (en) 2000-09-15 2003-04-24 Gish Kurt C. Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
WO2002024956A2 (en) 2000-09-19 2002-03-28 Whitehead Institute For Biomedical Research Genetic markers for tumors
US20020150922A1 (en) 2000-11-20 2002-10-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
WO2002074156A2 (en) * 2001-02-02 2002-09-26 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
EP1402068A4 (en) * 2001-05-09 2006-07-12 Univ Cleveland Hospitals EVALUATION OF SKIN DAMAGE CAUSED BY ULTRAVIOLET RAYS USING NEW GENE MARKERS, METHODS AND COMPOSITIONS THEREOF
US20030148314A1 (en) * 2001-08-01 2003-08-07 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of colon cancer
US7622260B2 (en) 2001-09-05 2009-11-24 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests
JP5236856B2 (ja) 2001-11-09 2013-07-17 ライフ テクノロジーズ コーポレーション 遺伝子発現プロファイルを用いる病気の同定、観測及び治療及び生物学的状態の同定
US20030225526A1 (en) 2001-11-14 2003-12-04 Golub Todd R. Molecular cancer diagnosis using tumor gene expression signature
AU2002357747A1 (en) * 2001-12-10 2003-06-23 Millennium Pharmaceuticals Inc. Novel genes encoding colon cancer antigens
EP1534739A4 (en) 2002-01-18 2006-05-31 Bristol Myers Squibb Co IDENTIFICATION OF POLYNUCLEOTIDES AND POLYPEPTIDES FOR PREDICTING THE ACTIVITY OF COMPOUNDS THAT INTERACT WITH TYROSINE KINASE PROTEINS AND / OR TYROSINE KINASE PROTEIN PATHWAYS
US7955800B2 (en) 2002-06-25 2011-06-07 Advpharma Inc. Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients
CA2498418A1 (en) 2002-09-10 2004-03-25 Guennadi V. Glinskii Gene segregation and biological sample classification methods
JP2006515318A (ja) 2002-10-29 2006-05-25 ファルマシア・コーポレーション 特異的に発現する癌関連遺伝子、それによってコードされるポリペプチドおよびその使用方法
US7767391B2 (en) 2003-02-20 2010-08-03 Genomic Health, Inc. Use of intronic RNA to measure gene expression
ES2905579T3 (es) 2003-07-10 2022-04-11 Genomic Health Inc Algoritmo del perfil de expresión y prueba para el pronóstico de la recaída del cáncer de mama
WO2005015236A2 (en) 2003-07-18 2005-02-17 Roche Diagnostics Gmbh A method for predicting the progression of adenocarcinoma
US20050014165A1 (en) 2003-07-18 2005-01-20 California Pacific Medical Center Biomarker panel for colorectal cancer
JP2007507204A (ja) * 2003-07-29 2007-03-29 ブリストル−マイヤーズ　スクイブ　カンパニー サイクリン依存性キナーゼモデュレーションのバイオマーカー
EP1892306A3 (en) 2003-10-06 2008-06-11 Bayer HealthCare AG Methods and kits for investigating cancer
WO2005076005A2 (en) 2004-01-30 2005-08-18 Medizinische Universität Wien A method for classifying a tumor cell sample based upon differential expression of at least two genes
US20060195266A1 (en) 2005-02-25 2006-08-31 Yeatman Timothy J Methods for predicting cancer outcome and gene signatures for use therein
CA2562835A1 (en) 2004-04-16 2005-10-27 Monash University A method for monitoring the progress of cancer
CA2574447A1 (en) 2004-07-15 2006-01-26 University Of Utah Research Foundation Housekeeping genes and methods for identifying the same
US20060183893A1 (en) 2005-01-25 2006-08-17 North Don A Nucleic acids for apoptosis of cancer cells
WO2006110585A2 (en) 2005-04-07 2006-10-19 Novartis Vaccines And Diagnostics Inc. Cancer-related genes (prlr)
WO2006138275A2 (en) 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US20090299640A1 (en) 2005-11-23 2009-12-03 University Of Utah Research Foundation Methods and Compositions Involving Intrinsic Genes
US20090215054A1 (en) 2005-12-13 2009-08-27 Carter Scott L Prognosis indicators for solid human tumors
NZ544432A (en) 2005-12-23 2009-07-31 Pacific Edge Biotechnology Ltd Prognosis prediction for colorectal cancer using a prognositc signature comprising markers ME2 and FAS
NZ593224A (en) 2006-01-11 2012-10-26 Genomic Health Inc Gene expression markers (fap) for colorectal cancer prognosis
WO2007112330A2 (en) 2006-03-24 2007-10-04 Diadexus, Inc. Compositions and methods for detection, prognosis and treatment of colon cancer
US20090258795A1 (en) 2007-03-15 2009-10-15 Genomic Health, Inc. Gene expression markers for prediction of patient response to chemotherapy
US8067178B2 (en) 2008-03-14 2011-11-29 Genomic Health, Inc. Gene expression markers for prediction of patient response to chemotherapy
US8765383B2 (en) 2009-04-07 2014-07-01 Genomic Health, Inc. Methods of predicting cancer risk using gene expression in premalignant tissue
SG10201401722XA (en) 2009-05-01 2014-08-28 Genomic Health Inc Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer andresponse to chemotherapy

Similar Documents

Publication Publication Date Title
JP2009523028A5 (enExample)
Zheng et al. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer
Shaath et al. Molecular classification of breast cancer utilizing long non-coding RNA (lncRNA) transcriptomes identifies novel diagnostic lncRNA panel for triple-negative breast cancer
Yu et al. Identification of an m6A-related lncRNA signature for predicting the prognosis in patients with kidney renal clear cell carcinoma
Cho et al. Gene expression signature–based prognostic risk score in gastric cancer
Kim et al. Synergistic effect of different levels of genomic data for cancer clinical outcome prediction
Christodoulidis et al. Gastric cancer in the era of epigenetics
JP2014532428A5 (enExample)
JP2009516501A5 (enExample)
NZ593228A (en) Gene expression markers (inhba) for colorectal cancer prognosis
JP2016174600A5 (enExample)
JP2010538609A5 (enExample)
Zhang et al. Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study
Lorusso et al. miRNAs as key players in the management of cutaneous melanoma
Ye et al. A multi-omics network of a seven-gene prognostic signature for non-small cell lung cancer
Wu et al. Predictive value of miR‐219‐1, miR‐938, miR‐34b/c, and miR‐218 polymorphisms for gastric cancer susceptibility and prognosis
Xu et al. Identification of fatty acid metabolism–related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma
Ding et al. Exploration of the associations of lncRNA expression patterns with tumor mutation burden and prognosis in colon cancer
Ye et al. MicroRNA-based discovery of biomarkers, therapeutic targets, and repositioning drugs for breast cancer
Yu et al. Comprehensive analysis of mitophagy-related genes in NSCLC diagnosis and immune scenery: based on bulk and single-cell RNA sequencing data
Song et al. The LINC00261/MiR105-5p/SELL axis is involved in dysfunction of B cell and is associated with overall survival in hepatocellular carcinoma
Mohd Faizal et al. A narrative review of prognostic gene signatures in oral squamous cell carcinoma using LASSO Cox regression
Meng et al. WGCNA and LASSO algorithm constructed an immune infiltration-related 5-gene signature and nomogram to improve prognosis prediction of hepatocellular carcinoma
Wei et al. An efficient and easy-to-use network-based integrative method of multi-omics data for cancer genes discovery
Ding et al. Identification and validation of UBE2B as a prognostic biomarker promoting the development of esophageal carcinomas